Polycystic kidney disease in patients on the renal transplant waiting list: trends in hematocrit and survival.
BACKGROUND
The patient characteristics and mortality associated with autosomal dominant polycystic kidney disease (PKD) have not been characterized for a national sample of end stage renal disease (ESRD) patients on the renal transplant waiting list.


METHODS
40,493 patients in the United States Renal Data System who were initiated on ESRD therapy between 1 April 1995 and 29 June 1999 and later enrolled on the renal transplant waiting list were analyzed in an historical cohort study of the relationship between hematocrit at the time of presentation to ESRD and survival (using Cox Regression) in patients with PKD as a cause of ESRD.


RESULTS
Hematocrit levels at presentation to ESRD increased significantly over more recent years of the study. Hematocrit rose in parallel in patients with and without PKD, but patients with PKD had consistently higher hemoglobin. PKD was independently associated with higher hematocrit in multiple linear regression analysis (p < 0.0001). In logistic regression, higher hematocrit was independently associated with PKD. In Cox Regression analysis, PKD was associated with statistically significant improved survival both in comparison with diabetic (hazard ratio, 0.64, 95% CI 0.53-0.77, p < 0.001) and non-diabetic (HR 0.68, 95% CI 0.56-0.82, p = 0.001) ESRD patients, adjusted for all other factors.


CONCLUSIONS
Hematocrit at presentation to ESRD was significantly higher in patients with PKD compared with patients with other causes of ESRD. The survival advantage of PKD in ESRD persisted even adjusted for differences in hematocrit and in comparison with patients on the renal transplant waiting list.
Nephrology Service, Walter Reed Army Medical Center, Washington, DC, USA. kevin.abbott@na.amedd.army.mil
Kevin C
KC
Abbott
Lawrence Y
LY
Agodoa
D005260:Female; D006400:Hematocrit / Q000706:statistics & numerical data*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000401:mortality / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D007690:Polycystic Kidney Diseases / Q000378:metabolism* / Q000401:mortality* / Q000628:therapy; D012042:Registries / Q000706:statistics & numerical data; D012044:Regression Analysis; D006435:Renal Dialysis; D015996:Survival Rate; D014481:United States / Q000453:epidemiology; D014850:Waiting Lists